Debate over Korean anti-aging treatment
South Korea has introduced a new anti-aging treatment that involves extracting skin tissues from deceased individuals to use in rejuvenating the skin, sparking ethical and scientific controversy. The treatment is called "Elravie Re2O" and works by stimulating skin cells to produce collagen naturally, while providing structural support to rebuild damaged tissue. Despite mixed trial results and severe pain reported by some users, it has not yet received approval from the U.S. Food and Drug Administration, and the manufacturing company aims to obtain licensing by 2027. This treatment raises ethical questions regarding the use of human tissues and presents challenges concerning its long-term safety and effectiveness.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading